Patent Issued for Systems and methods for bioprocessing (USPTO 11920119).

A patent has been issued for a bioprocessing system and methods for the production of cellular immunotherapies. The system aims to reduce contamination risk by increasing automation and decreasing human handling. It consists of three modules: one for enriching and isolating cells, one for activating and genetically modifying the cells, and one for harvesting the expanded cells. The system allows for parallel and asynchronous processing of multiple populations of cells and is designed to be flexible and adaptable to different customer processes. [Extracted from the article]